Source: DGNews  |  Posted 8 years ago

RESEARCH TRIANGLE PARK, NC and LONDON, ENGLAND -- June 26, 2003 -- GlaxoSmithKline announced today it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the antidepressant Wellbutrin XL